Cambridge Quantum Computing (CQC) to Collaborate with Roche for Development of Alzheimer's Diseas...

The two companies have announced a multi-year agreement to use CQC's "EUMEN" computational chemistry platform to design and implement noisy-intermediate-scale-quantum (NISQ) algorithms for early-stage drug discovery and development and augment Roche's Alzheimer’s disease research efforts. EUMEN is a software package developed by CQC to facilitate the design of pharmaceuticals, specialty chemicals, performance materials and agrochemicals using the power of quantum computation. Additional details are available in the news release on the CQC website here.

January 28, 2021